Kayser S, Schlenk RF. All patients with AML and FLT3-ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? – the PRO. haematol [Internet]. 2026Apr.1 [cited 2026Apr.13];111(4):1149-52. Available from: https://haematologica.org/article/view/13095